Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The effects of d-amphetamine (0.5 mg/kg PO) on regional cerebral glucose utilization were measured with Positron Emission Tomography (PET). Subjects included ten chronic schizophrenics and six controls who received amphetamine, and six chronic schizophrenics and nine controls who received placebo or no treatment. Amphetamine decreased glucose metabolism in all regions studied (frontal, temporal, and striatal) in normal and schizophrenic subjects. The metabolic effects of amphetamine were correlated with plasma level of the drug. Cortical atrophy was associated with a blunted metabolic response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effects of AMP on regional CBF appear to be dependent on the dose, with lower doses decreasing rates of blood flow in the frontal and temporal cortices and in the striatum (163) and higher doses increasing blood flow in the anterior cingulate cortex, caudate nucleus, putamen, and thalamus (160).”
Citations
Cites
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Noninvasive determination of local cerebral metabolic rate of glucose in man
Huang, S. C., Phelps, M. E., Hoffman, E. J., Sideris, K., Selin, C. J., & Kuhl, D. E. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.1.e69 · Cited by 925
Wong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., Gjedde, A., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 697
Buchsbaum, M. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030001001 · Cited by 535
The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.
ANGRIST, B. M., & Gershon, S. (1970) · PubMed · Cited by 477
Self-citationAnteroposterior Gradients in Cerebral Glucose Use in Schizophrenia and Affective Disorders
Buchsbaum, M. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790230045007 · Cited by 369
Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate
Janowsky, D. S. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750320023004 · Cited by 310
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.564 · Cited by 293
Self-citationMechanisms of thermal adaptation in bacteria: blueprints for survival
RUSSELL, N. (1984) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(84)90106-3 · Cited by 250
DUARA, R., MARGOLIN, R. A., ROBERTSON-TCHABO, E. A., LONDON, E. D., SCHWARTZ, M., RENFREW, J. W., KOZIARZ, B. J., SUNDARAM, M., GRADY, C., MOORE, A. M., et al. (1983) · Brain · doi:10.1093/brain/106.3.761 · Cited by 228
Cited by
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
Benkelfat, C. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210048007 · Cited by 539
Changes in brain glucose metabolism in cocaine dependence and withdrawal
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.621 · Cited by 455
Self-citationNegative Symptoms and Hypofrontality in Chronic Schizophrenia
Wolkin, A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120047007 · Cited by 393
Self-citation"Loss of control" in alcoholism and drug addiction: A neuroscientific interpretation.
Lyvers, M. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.2.225 · Cited by 311
London, E. D. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180067010 · Cited by 305
PET evaluation of the dopamine system of the human brain.
Volkow, N. D., Fowler, J., Sj, G., Logan, J., Wang, G., Ding, Y., & Dewey, S. L. (1996) · PubMed · Cited by 299
Daniel, D., Weinberger, D., Jones, D., Zigun, Jr., Coppola, R., Handel, S., Bigelow, L., Goldberg, T., Berman, K., & Kleinman, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-07-01907.1991 · Cited by 277
Cortical Pruning and the Development of Schizophrenia: A Computer Model
Hoffman, R. E., & Dobscha, S. K. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.3.477 · Cited by 269
Gouzoulis-Mayfrank, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00089-x · Cited by 219
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., & Hollister, L. (1996) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(96)02817-x · Cited by 219
Positron Emission Tomography Studies of Abnormal Glucose Metabolism in Schizophrenia
Buchsbaum, M. S., & Hazlett, E. A. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033331 · Cited by 211
Smith, P. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00092-4 · Cited by 201
Self-citationAcute effects of ethanol on regional brain glucose metabolism and transport
Volkow, N. D., Hitzemann, R., Wolf, A. P., Logan, J., Fowler, J. S., Christman, D., Dewey, S. L., Schlyer, D., Burr, G., Vitkun, S., et al. (1990) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(90)90007-s · Cited by 184
Self-citationStriatal Metabolic Rate and Clinical Response to Neuroleptics in Schizophrenia
Buchsbaum, M. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120054008 · Cited by 181
Brain glucose metabolism in borderline personality disorder
De la Fuente, J., Goldman, S., Stanus, E., Vizuete, C., Morlán, I., Bobes, J., & Mendlewicz, J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00001-0 · Cited by 180
Berti (2014) · doi:10.1016/j.cpet.2013.10.006 · Cited by 152
Substance abuse and cerebral blood flow
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.3.292 · Cited by 148
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.658 · Cited by 129
London, E. D. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810130075010 · Cited by 128
Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys
Huston-Lyons, D., Friedman, D. P., Nader, M. A., & Porrino, L. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01230.1996 · Cited by 128
Gollub, R. L., Breiter, H. C., Kantor, H., Kennedy, D., Gastfriend, D., Mathew, R. T., Makris, N., Guimaraes, A., Riorden, J., Campbell, T., et al. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199807000-00003 · Cited by 121
Decreased frontal white-matter volume in chronic substance abuse
Schlaepfer, T. E., Lancaster, E., Heidbreder, R., Strain, E. C., Kosel, M., Fisch, H., & Pearlson, G. D. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005705 · Cited by 121
Neuropsychiatric rehabilitation for persistent mental illness
Jaeger, J., & Douglas, E. (1992) · Psychiatric Quarterly · doi:10.1007/bf01064683 · Cited by 118
Self-citationEffects of Acute Stimulant Medication on Cerebral Metabolism in Adults with Hyperactivity
Matochik, J. A., Nordahl, T. E., Gross, M., Semple, W. E., King, A. C., Cohen, R. M., & Zametkin, A. J. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.38 · Cited by 105
Volkow, N. D., Gillespie, H. K., Mullani, N. A., Tancredi, L., Grant, C., Ivanović, M., & Hollister, L. E. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90030-t · Cited by 101
The Impact of Substance Abuse on Mortality in Patients With Severe Traumatic Brain Injury
O’Phelan, K. H., McArthur, D. L., Chang, C. W. J., Green, D. M., & Hovda, D. A. (2008) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31817db0a5 · Cited by 93
Voxel-based morphometry in narcolepsy
Brenneis, C., Brandauer, E., Frauscher, B., Schocke, M. F. H., Trieb, T., Poewe, W. H., & Högl, B. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.03.015 · Cited by 88
Vollenweider, F. X., Maguire, R. P., Leenders, K. L., Mathys, K., & Angst, J. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00033-x · Cited by 83
Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse
Berman, S. M., Voytek, B., Mandelkern, M. A., Hassid, B. D., Isaacson, A. J., Monterosso, J. R., Miotto, K. A., Ling, W. W., & London, E. D. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002107 · Cited by 79
Low frontal glucose utilization in chronic schizophrenia: a replication study
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.2.251 · Cited by 74
Self-citationThe effect of apomorphine on regional cerebral blood flow in schizophrenia
Daniel, D. G., Berman, K. F., & Weinberger, D. R. (1989) · Journal of Neuropsychiatry · doi:10.1176/jnp.1.4.377 · Cited by 74
Negative Symptoms in Schizophrenia: Neurobiological Models and Treatment Response
Goff, D. C., & Evins, E. A. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000313 · Cited by 65
Behavioral Sensitization in Humans
Sax, K. W., & Strakowski, S. M. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_06 · Cited by 68
Friedman, J. I., Carpenter, D. M., Lü, J., Jin, F., Tang, C. Y., WHITE, L. E., Parrella, M. J., Bowler, S., Elbaz, Z. S., Flanagan, L., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318161318f · Cited by 66
Cocaine-Induced Increases in EEG Alpha and Beta Activity: Evidence for Reduced Cortical Processing
Herning, R. I., Glover, B. J., Koeppl, B., Phillips, R. L., & London, E. D. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.30 · Cited by 65
A Comparison of Drug Conditioning and Craving for Alcohol and Cocaine
Newlin, D. B. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_8 · Cited by 59
Lingford-Hughes, A. R., Davies, S., McIver, S. R., Williams, T. A., Daglish, M. R. C., & Nutt, D. J. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.209 · Cited by 58
Bailer, U. F., Narendran, R., Frankle, W. G., Himes, M. L., Duvvuri, V., Mathis, C. A., & Kaye, W. H. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.20937 · Cited by 55
PET Measurement of Dopamine D2Receptor-Mediated Changes in Striatopallidal Function
BLACK, K. J., Gado, M. H., & Perlmutter, J. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03168.1997 · Cited by 53
Amphetamine and negative symptoms of schizophrenia
Sanfilipo, M. P., Wolkin, A., ANGRIST, B. M., Duncan, E., Wieland, S., Peselow, E. D., Rotrosen, J., van Kammen, D. P., & Cooper, T. B. (1996) · Psychopharmacology · doi:10.1007/bf02246180 · Cited by 52
Self-citationChanges in rat brain energetic metabolism after exposure to anandamide or Δ9-tetrahydrocannabinol
Costa, B., & Colleoni, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00170-9 · Cited by 52
(2001) · PubMed · Cited by 47
Wolkin, A., Sanfilipo, M. P., Duncan, E., Angrist, B., Wolf, A. P., Cooper, T. B., Brodie, J. D., LASKA, E. M., & Rotrosen, J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.346 · Cited by 46
Self-citationBasselin, M., Ramadan, E., & Rapoport, S. I. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.12.001 · Cited by 45
de Haes, J. I. U., Maguire, R. P., Jager, P. L., Paans, A. M. J., & den Boer, J. A. (2007) · Human Brain Mapping · doi:10.1002/hbm.20293 · Cited by 35
Addiction and imaging of the living human brain
Gatley, S. J., & Volkow, N. D. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00069-6 · Cited by 42
Wolkin, A., Sanfilipo, M. P., ANGRIST, B. M., Duncan, E., Wieland, S., Wolf, A. P., Brodie, J. D., Cooper, T. B., LASKA, E. M., & Rotrosen, J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90629-7 · Cited by 41
Self-citationPET imaging of dopamine receptors in human basal ganglia: relevance to mental illness
Sedvall, G. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90114-p · Cited by 41
Intravenous Dextroamphetamine and Brain Glucose Metabolism
Ernst, M., Zametkin, A. J., Matochik, J., Schmidt, M., Jons, P. H., Liebenauer, L. L., Hardy, K. K., & Cohen, R. M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00088-2 · Cited by 40
Willson, M. C., Wilman, A. H., Bell, E. C., Asghar, S. J., & Silverstone, P. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.008 · Cited by 36
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia
Bartlett, E. J., Barouche, F., Brodie, J. D., Wolkin, A., Angrist, B., Rotrosen, J., & Wolf, A. P. (1991) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(91)90025-l · Cited by 36
Self-citationDissociated effects of amphetamine on arousal and cortical blood flow in humans
Kahn, D. A., Prohovnik, I., Lucas, L. R., & Sackeim, H. A. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90247-3 · Cited by 36
Tipper, C. M., Cairo, T. A., Woodward, T. S., Phillips, A. G., Liddle, P. F., & Ngan, E. T. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0025-4 · Cited by 34
Visuoperceptual and visuomotor deficits in developmental stutterers: An exploratory study
Jones, R. D., White, A. J., Lawson, K. H. C., & Anderson, T. (2002) · Human Movement Science · doi:10.1016/s0167-9457(02)00165-3 · Cited by 33
Amphetamines for schizophrenia
Nolte, S., Wong, D., Latchford, G. J., Boyle, O., & Anaenugwu, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004964 · Cited by 30
Sutton, R. L., Hovda, D. A., Chen, M. J., & Feeney, D. M. (2000) · Neural Plasticity · doi:10.1155/np.2000.109 · Cited by 30
Buprenorphine Reduces Cerebral Glucose Metabolism in Polydrug Abusers
WALSH, S. L., Gilson, S. F., Jasinski, D. R., Stapleton, J. M., Phillips, R. L., Dannals, R. F., Schmidt, J., Preston, K. L., GRAYSON, R. F., Bigelow, G. E., et al. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.18 · Cited by 30
Kleinschmidt, A. K., Bruhn, H., Krüger, G., Merboldt, K. D., Stoppe, G., & Frahm, J. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199908)12:5<286::aid-nbm576>3.0.co;2-q · Cited by 30
Ethical problems in psychiatric research
Lehrman, N. S., & Sharav, V. H. (1997) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02898516 · Cited by 29
Functional correlates of nicotine administration: similarity with drugs of abuse
Pontieri, F. E., Passarelli, F., Calò, L., & Caronti, B. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050208 · Cited by 27
Bench, C. J., Dolan, R. J., Friston, K. J., & Frackowiak, R. S. J. (1990) · The British Journal of Psychiatry · doi:10.1192/s0007125000291885 · Cited by 27
The Use and Applications of Single-Photon Emission Computerised Tomography in Dementia
Geaney, D. P., & Abou‐Saleh, M. T. (1990) · The British Journal of Psychiatry · doi:10.1192/s0007125000291861 · Cited by 25
Effects of amisulpride on human resting cerebral perfusion
Viviani, R., Graf, H., Wiegers, M., & Abler, B. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3091-z · Cited by 24
van Dyck, C. H., Rosen, M. I., Thomas, H. M., McMahon, T. J., Wallace, E. A., O’Connor, P. G., Sullivan, M. C., Krystal, J. H., Hoffer, P. B., Woods, S. W., et al. (1994) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(94)90013-2 · Cited by 23
London, E. D., Stapleton, J. M., Grant, S. J., Phillips, R. L., Villemagne, V. L., Liu, X., & Soria, R. (1996) · PsycEXTRA Dataset · doi:10.1037/e495672006-008 · Cited by 23
Nordin, L. E., Li, T., Brogren, J., Johansson, P., Sjögren, N., Hannesdóttir, K., Björk, C., Segerdahl, M., Wang, D. J. J., & Julin, P. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.11.035 · Cited by 22
Differential effects of cocaine on local cerebral glucose utilization in the mouse and in the rat
Zocchi, A., Conti, G., & Orzi, F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01898-5 · Cited by 22
Angrist, B., Sanfilipo, M. P., & Wolkin, A. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200105000-00004 · Cited by 21
Self-citationAcute Pharmacological Treatment of Schizophrenia
Miyamoto, S., Stroup, T. S., Duncan, G. E., Aoba, A., & Lieberman, J. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch24 · Cited by 20
Schreckenberger, M., Gouzoulis‐Mayfrank, E., Sabri, O., Arning, C., Zimny, M., Zeggel, T., Wagenknecht, G., Kaiser, H.-J., Saß, H., & Buell, U. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050497 · Cited by 20
Morgan, M. J., Cascella, N. G., Stapleton, J. M., Phillips, R. L., Yung, B. C., Wong, D. F., Shaya, E. K., & London, E. D. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1712 · Cited by 20
Waddington, J. L. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.156.5.615 · Cited by 19
Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development
Sevarino, K. A., Oliveto, A. H., & Kosten, T. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06676.x · Cited by 16
Psychotic Continuum or Distinct Entities: Perspective from Psychopharmacology
Meltzer, H. Y. (1995) · Springer eBooks · doi:10.1007/978-3-642-79485-8_4 · Cited by 16
Openshaw, R. L., Thomson, D. M., Thompson, R., Penninger, J. M., Pratt, J. A., Morris, B., & Dawson, N. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz044 · Cited by 15
Gatley, S. J., Gifford, A. N., Volkow, N. D., & Fowler, J. S. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_11 · Cited by 14
The Neurobiology of Attention-Deficit Hyperactivity Disorder: A Synopsis
Zametkin, A. J. (1989) · Psychiatric Annals · doi:10.3928/0048-5713-19891101-07 · Cited by 14
Chapter 28 New Directions in Positron Emission Tomography-Part II
Fowler, J. S., Wolf, A. P., & Volkow, N. D. (1990) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61604-8 · Cited by 13
Self-citationRegional brain glucose metabolism after acute α2-blockade by idazoxan
Schmidt, M. E., Matochik, J. A., Risinger, R. C., Schouten, J. L., Zametkin, A. J., Cohen, R. M., & Potter, W. Z. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90232-5 · Cited by 12
Tsai, S., Huang, Y.-H., Chang, L.-S., Yang, Y., & Sim, C. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02496-j · Cited by 9
Single Photon Emission Tomography
Geaney, D. P. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_25 · Cited by 9
Ramchand, C. N., GLIDDON, A. E., Clark, A. E., & Hemmings, G. P. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00131-o · Cited by 8
The early identification of psychosis: can lessons be learnt from cardiac stress testing?
Gupta, S., Ranganathan, M., & D’Souza, D. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4143-3 · Cited by 7
Jones, A. K. P., Friston, K. J., & Dolan, R. J. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80103-x · Cited by 6
Choi, S., Magata, Y., Saji, H., Tajima, K., Kitano, H., Konishi, J., & Yokoyama, A. (1997) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199709)11:6<437::aid-ptr124>3.0.co;2-i · Cited by 6
Positron Emission Tomography in Psychopharmacology
Dolan, R. J., Bench, C. J., & Friston, K. J. (1990) · International Review of Psychiatry · doi:10.3109/09540269009026611 · Cited by 4
Lecompte, D., Mertens, C., Binder, M. D., Vandendriessche, F., Bleeker, E. D., Hulselmans, J., Janssen, F., Peuskens, J., & Wampers, M. (2011) · Neuron · Cited by 2
18F-FDG PET/CT Indications, Pitfalls and Limitations in Brain Imaging
Vöö, S. A., & Bomanji, J. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-01523-7_9 · Cited by 2
Imaging Studies in Substance Abuse
Volkow, N. D., Fowler, J. S., Wang, G., & Shreeve, W. W. (2003) · Springer eBooks · doi:10.1007/978-3-642-55539-8_18 · Cited by 2
Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment
Wiesel, F. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90105-n · Cited by 2
In vivo imaging of dopamine and serotonin release: response to psychopharmacological challenges
de Haes, J. I. U. (2000) · Cited by 1
12. Amphetamine response and duration of illness in schizophrenia
Angrist, B., Sanfilipo, M. P., & Wolkin, A. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90072-y · Cited by 1
Self-citationExploring Frontal Lobe Dysfunction in Schizophrenia with Positron Emission Tomography
Hall, D. P. (1990) · Jefferson Journal of Psychiatry · doi:10.29046/jjp.008.1.006 · Cited by 1
Positron Emission Tomography of the Reward System
Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · Neuromethods · doi:10.1007/978-1-0716-1146-3_14 · Cited by 1
Studies of the brain cannabinoid system using positron emission tomography
Gatley, S. J., & Volkow, N. D. (1995) · University of North Texas Digital Library (University of North Texas) · Cited by 1
Prediction of clinical response to neuroleptics and positron emission tomography in schizophrenia
Buchsbaum, M. S., & Luu, C. (1994) · Springer eBooks · doi:10.1007/978-3-7091-6636-9_13 · Cited by 1
Telang, F., & Vblkow, N. D. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50025-1
Functional Imaging for the Monitoring of Clinical Outcomes of Pharmacotherapy
Bednarczyk, E. M. (2001) · Journal of Pharmacy Practice · doi:10.1106/t955-v189-ltap-38my
Studies of the Brain Cannabinoid System Using Positron and Single-Photon Emission Tomography
Gatley, S. J., Volkow, N. D., & Makriyannis, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_17
Metadata
- Authors
- Wolkin, A., Angrist, B., Wolf, A., Brodie, J., Wolkin, B., Jaeger, J., Cancro, R., & Rotrosen, J.
- Affiliations
- United States Department of Veterans Affairs (US)
- Brookhaven National Laboratory (US)
- New York University (US)
- Manhattan Psychiatric Center (US)
- Venue
- Psychopharmacology
- Published
- 1987-06
- Volume
- 92
- Issue
- 2
- Pages
- 241-6
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2011886002
- Cited by
- 100
- References
- 40
- Citations by year
- 2020: 1 · 2019: 2 · 2018: 1 · 2015: 1 · 2013: 2 · 2012: 1
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (15638)
- National Institute of Mental Health (MH 35976)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- amphetamine, schizophrenia, regional cerebral glucose metabolism, d-amphetamine, cortical atrophy, striatum, frontal cortex, temporal cortex, plasma drug concentration, drug-induced metabolic effects
- MeSH terms
- Adult, Amphetamine, Brain, Brain Chemistry, Chronic Disease, Humans, Kinetics, Male, Middle Aged, Schizophrenia, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.